Global firms in India are hiring cautiously. Artificial intelligence is changing job roles, making it harder to find talent with advanced t...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

In a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

Amazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...

Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, mark...

A high dividend yield by itself is not a sign of safety. Sometimes, a stock yields more only because the price has collapsed for a valid re...

Union Minister Piyush Goyal has sharply criticized the DMK government in Tamil Nadu. He questioned Chief Minister MK Stalin about the state...

Hyderabad-based Bharat Biotech is developing novel vaccines to combat antimicrobial resistance (AMR), a significant global health threat. T...

IIT Madras and Ohio State University researchers have unveiled PURE, an AI framework that generates drug-like molecules with enhanced lab s...

Absci's collaboration with AstraZeneca aims for a zero-shot generative AI model designed to create new and improved antibody therapeutics

The deal adds promising drug candidates to Merck's oncology portfolio, as its bestselling cancer therapy Keytruda will see its patent expir...

This is the first example of taking a genetic sequence and designing a drug candidate that works effectively.

A new malaria vaccine candidate has been found to generate robust immune response while significantly delaying parasitemia in 59 per cent o...

Senior Aam Aadmi Party leader Yogendra Yadav today accused SAD-BJP govt of failing to protect youth from drugs and allowing sand mafia to f...

Jubilant Biosys today said it has entered into drug discovery collaboration with Mnemosyne Pharmaceutical Inc.

Healthcare major, Zydus Cadila has filed IND (Investigational New Drug) application for anti-diabetic and anti-obesity drug with Drugs Cont...